Acorda Therapeutics, Inc. (ACOR) Q3 2023 Earnings Call Transcript
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Tierney Saccavino - ...
Thursday, May 8, 2025
Tag: Therapeutics
CytomX Therapeutics Reports Q3 2023 Results, Highlights Pipeline Progress and Strategic Partnerships By Investing.com
© Reuters. CytomX Therapeutics (NASDAQ:), a company dedicated to the discovery and development of novel cancer medicines, has reported its ...
Nektar Therapeutics (NKTR) Q3 2023 Earnings Call Transcript
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, ...
Bristol-Myers Squibb to acquire Mirati Therapeutics for $4.8B
Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. ...
Stocks making biggest moves midday: Rivian, Orchard Therapeutics
McDonald's french fries being prepared.Daniel Acker | Bloomberg | Getty ImagesCheck out the companies making headlines in midday trading.Rivian Automotive ...
Structure Therapeutics Stock: Tipping The Scales In Obesity Management (NASDAQ:GPCR)
Milko Maintaining a Buy Rating for Structure Therapeutics Following the Positive Clinical Data Readout of GSBR-1290 In the fast-evolving world ...
Rani Therapeutics Stock: Excellent Technology But Major Risks Ahead (NASDAQ:RANI)
D3Damon/E+ via Getty Images Overview of the thesis Rani Therapeutics (NASDAQ:RANI) is developing a robotic pill to allow oral delivery ...
BrainStorm Cell Therapeutics; I Anticipate A Positive AdCom But There Are Major Risks
koto_fejaOverview of the thesis Brainstorm Cell Therapeutics (NASDAQ:BCLI) is developing cellular therapies for neurodegenerative diseases. BCLI has completed a phase ...
Stoke Therapeutics Is Unable To Derisk Its Platform (NASDAQ:STOK)
chemicalbillyI covered Stoke Therapeutics (NASDAQ:STOK) in February, and although I was mildly positive, I am lucky I didn’t go out ...
US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics By Reuters
© Reuters. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.